'Transformative' HIV PrEP shot slowly overcomes cost hurdles

HIV/AIDS activists heralded the approval of a new twice-yearly pre-exposure prophylaxis (PrEP) medication last year, but ...
The New England Journal of Medicine

Long-Acting HIV Medicines and the Pandemic Inequality Cycle — Rethinking Access

The world may look back on 2024 as a pivotal time in the fight against AIDS — the start of a revolution in the global biomedical response to HIV using long-acting antiretroviral medicines. Young women ...
Forbes

The Beginning Of HIV’s End: Innovative Technologies Changing HIV Care

I came of age during the height of the AIDS crisis in the '90s. I was just starting my career in the pharmaceutical industry as the epidemic hit its peak, and the anxiety and concern surrounding it ...